INTERPHEX 2016 Keynote Series

Pharmaceutical Processing

Developed by Pharmaceutical Technology and INTERPHEX, this comprehensive 2-day Keynote Series features industry experts delivering insight on key industry themes including drug shortage, overcoming bottlenecks, technology advances in solid dosage, sterile manufacturing challenges and contract services market overview.

Overcoming Bottlenecks in Biopharmaceutical Development
Panel discussion on how technology advances are addressing challenges in biopharma development including QC of raw materials, implementation of SUT, process monitoring, and downstream purification.

Innovations in Solid Dosage Development and Manufacturing
New OSD development and manufacturing technologies offer new options for patients. In this session, experts will discuss advances in new solid dosage forms.

  • Drop-On-Demand Manufacturing System for the Flexible Production of Solid Dosage Forms
  • Polymer Thin Films for Drug Delivery: Process and PAT Development

Back by Popular Demand, Jim Miller's, Contract Services Market: 2016 Update
In his annual presentation, Jim offers his perspectives on the contract services landscape for the next few years. How will consolidation in the bio/pharmaceutical and contract services market, a changing financial market, and an active political and regulatory year shape the fortunes of the contract services market?

Strategies and Innovations to Reduce Drug Shortages and Improve Availability of Medicines
In this session, industry thought leaders identify triggers for drug shortages, methods to avoid production line shutdowns and update facilities, and innovative industry efforts to fulfill demand for needed therapies.

  • An Interdisciplinary Approach to Address Drug Shortages
  • Perspectives on New Manufacturing Technologies
  • Promoting Adoption of Continuous Manufacturing to Address Availability of Drugs

Panel Discussion: Addressing Sterile Manufacturing Challenges
Sterile injectables have been in extremely short supply, and industry efforts have been focusing on root causes involving infrastructure, quality, and efficiency. Experts discuss recent initiatives, and offer insights into what must be done to prevent injectables shortages in the future.

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.